メディケアの受給者におけるトランスキャセター大動脈弁置換後の結果: 脆弱性と社会的脆弱性の影響
Gregory P Fontana1,2, Harun Kundi3, Steven V Manoukian2
1Los Robles Regional Medical Center, Thousand Oaks, California, USA.
Structural heart : the journal of the Heart Team
|September 2, 2025
まとめ
トランスキャテーター大動脈弁置換 (TAVR) を受けている患者の長期的死亡率の予測を著しく改善します. これらの要因は,TAVR手順の後の5年生存率を正確に評価するために不可欠です.
科学分野:
- 心血管医学
- 医療サービス研究
- 高齢者医療
背景:
- トランスキャテーター大動脈弁置換 (TAVR) は重度の大動脈狭窄症の重要な治療法です.
- TAVR後の長期的な死亡率の予測は,多様な患者集団でさらなる研究が必要である.
- この研究は,TAVRを受けるメディケア受給者の大規模な全国的なコホートにおける5年間の成果を検証しています.
研究 の 目的:
- メディケアの受給者におけるTAVRの5年間の成果を特徴づける.
- 人口統計,併発症,手続き的要因,脆弱性,社会的な脆弱性の遅い死亡リスクの予測価値を評価する.
主な方法:
- TAVRを受ける65歳以上の患者のためのMedicareの料金対サービスMedPARデータベース (2017-2022) の分析.
- 漸進的な予測値を評価するために,連続的な多変数Coxモデルを構築する.
- C統計と統合的差別改善 (IDI) を使用したモデルのパフォーマンスの評価.
主要な成果:
- 合計371,248人のTAVR患者が対象となった.
- 併発症,病院/処置要因,脆弱性,社会的な脆弱性を含むモデルは,予測の正確さを徐々に改善しました.
- 脆弱性や社会的脆弱性を含む最終的なモデルは,最も高い精度 (C=0.705) を達成しました.
結論:
- 脆弱性と社会的脆弱性は,TAVR後の長期的な死亡率のリスク予測を大幅に高めます.
- TAVRの5年後の死亡率を予測するには,社会人口学的および脆弱性に関連する要因が不可欠です.
- これらの発見は,これらの要因をTAVR患者のリスク層分化に組み込むことを支持しています.
さらに関連する動画
05:53Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty
Published on: July 24, 2013
16.7K
07:27Exergaming in Older People Living with HIV Improves Balance, Mobility and Ameliorates Some Aspects of Frailty
Published on: October 6, 2016
10.4K
関連する概念動画
01:22Mitral Valve Prolapse II: Assessment and Management
39
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
39
01:27Mitral Stenosis IV: Nursing Management
41
A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
41
01:19Mitral Valve Prolapse III: Nursing Management
35
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
35
01:29Heart Failure II: Pathophysiology
37
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
37
01:30Heart Failure V: Medical Management
23
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
23
01:26Heart Failure III: Clinical Manifestations
42
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
42